WHO, UNFPA, and other agencies have collaborated to establish a common nonproprietary list of essential reproductive health medicines. This introductory guide is a companion to that work and provides an overview of the process for including reproductive health medicines on national essential medicines lists at the country level based on the essential medicines concept. The guide also presents the rationale for including these medicines on national essential medicines lists.
Corporate author(s): WHO; UNFPA; PATH
Publication date: 2006
487 KB PDF
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA